NCT02731820View on ClinicalTrials.gov

Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

August 30, 2017

Study Completion Date

September 30, 2017

Conditions
OsteopeniaBone Disease, Metabolic
Interventions
DIETARY_SUPPLEMENT

Potassium citrate

Kcitr 3.064 milligrams daily in two tablets by mouth (1.032 milligrams every 12 hours)

DIETARY_SUPPLEMENT

Placebo

Excipients: 3.064 milligrams daily in two tablets by mouth (1.032 milligrams every 12 hours)

DIETARY_SUPPLEMENT

Vitamin D3

400 IU/die Vitamin D3 daily by mouth

DIETARY_SUPPLEMENT

Calcium carbonate

500 mg/die calcium carbonate daily by mouth

Trial Locations (1)

40136

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT02731820 - Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia | Biotech Hunter | Biotech Hunter